Compounds > quinazolines
Page last updated: 2024-08-21

quinazolines and Constriction, Pathological

quinazolines has been researched along with Constriction, Pathological in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gao, L; Lu, HQ; Qin, XP; Yan, QJ; Yang, L; Zeng, SY1
Alter, ML; Chaykovska, L; Hocher, B; Hohmann, M; Klein, T; Kraft, R; Kutil, B; Reichetzeder, C; Tsuprykov, O; von Websky, K1
Clowes, AW; Fukai, N; Jalikis, F; Kenagy, RD; Kohler, TR; Min, SK1
Guerre, A; Hartl, DM; Katz, P1
Abels, BC; Branch, RA; Callis, JT; Sabra, R1

Other Studies

5 other study(ies) available for quinazolines and Constriction, Pathological

ArticleYear
Rutaecarpine prevents hypertensive cardiac hypertrophy involving the inhibition of Nox4-ROS-ADAM17 pathway.
    Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:6

    Topics: ADAM17 Protein; Angiotensin II; Animals; Aorta, Abdominal; Cardiomegaly; Constriction, Pathologic; Gene Expression Regulation; Humans; Hypertension; Indole Alkaloids; MAP Kinase Signaling System; Myocytes, Cardiac; NADPH Oxidase 4; Quinazolines; Rats; Rats, Inbred Dahl; Reactive Oxygen Species

2019
Effects of telmisartan and linagliptin when used in combination on blood pressure and oxidative stress in rats with 2-kidney-1-clip hypertension.
    Journal of hypertension, 2013, Volume: 31, Issue:11

    Topics: Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Benzoates; Blood Pressure; Cardiomegaly; Collagen Type I; Constriction, Pathologic; Cystatin C; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Fibrosis; Heart; Hypertension, Renovascular; Kidney; Linagliptin; Lipoproteins, LDL; Male; Oxidative Stress; Purines; Quinazolines; Random Allocation; Rats; Rats, Wistar; Surgical Instruments; Telmisartan

2013
Proliferative capacity of vein graft smooth muscle cells and fibroblasts in vitro correlates with graft stenosis.
    Journal of vascular surgery, 2009, Volume: 49, Issue:5

    Topics: Aged; Ankle; Becaplermin; Blood Pressure; Cell Proliferation; Cells, Cultured; Constriction, Pathologic; DNA Replication; Epidermal Growth Factor; Female; Fibroblasts; Graft Occlusion, Vascular; Heparin; Humans; Hyperplasia; Lower Extremity; Lysophospholipids; Male; Middle Aged; Myocytes, Smooth Muscle; Peripheral Vascular Diseases; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-sis; Quinazolines; Saphenous Vein; Sphingosine; Thrombin; Time Factors; Tyrphostins; Ultrasonography, Doppler, Duplex; Vascular Patency

2009
[Alpha-1-blockers (alfuzosin) for obstructive salivary gland diseases].
    Revue de stomatologie et de chirurgie maxillo-faciale, 2010, Volume: 111, Issue:3

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Colic; Constriction, Pathologic; Female; Follow-Up Studies; Humans; Hypersensitivity; Hypotension, Orthostatic; Lithotripsy; Male; Middle Aged; Parotid Diseases; Parotitis; Quinazolines; Retrospective Studies; Salivary Ducts; Salivary Gland Calculi; Salivary Gland Diseases; Submandibular Gland Diseases; Treatment Outcome

2010
Influence of the adenosine receptor antagonist, CGS 15943A, on renal function after reconstruction of chronic renal artery stenosis in the dog.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 262, Issue:1

    Topics: Adenosine; Animals; Constriction, Pathologic; Creatinine; Dogs; Hemodynamics; Kidney; Purinergic Antagonists; Quinazolines; Renal Artery; Renal Circulation; Triazoles

1992